Studies from Oregon Health & Science University (OHSU) Further Understanding of Breast Cancer (Abstract 5935: Non-allosteric inhibition of enolase 1 sensitizes triple-negative breast cancer for checkpoint inhibitors)

MLA

“Studies from Oregon Health & Science University (OHSU) Further Understanding of Breast Cancer (Abstract 5935: Non-Allosteric Inhibition of Enolase 1 Sensitizes Triple-Negative Breast Cancer for Checkpoint Inhibitors).” Obesity, Fitness & Wellness Week, Apr. 2024, p. 654. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.789262765&authtype=sso&custid=ns315887.

APA

Studies from Oregon Health & Science University (OHSU) Further Understanding of Breast Cancer (Abstract 5935: Non-allosteric inhibition of enolase 1 sensitizes triple-negative breast cancer for checkpoint inhibitors). (2024, April 13). Obesity, Fitness & Wellness Week, 654.

Chicago

Obesity, Fitness & Wellness Week. 2024. “Studies from Oregon Health & Science University (OHSU) Further Understanding of Breast Cancer (Abstract 5935: Non-Allosteric Inhibition of Enolase 1 Sensitizes Triple-Negative Breast Cancer for Checkpoint Inhibitors),” April 13. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.789262765&authtype=sso&custid=ns315887.